These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2503955)

  • 1. [Expression of the class II antigens of the major histocompatibility complex on the blood cells of psoriasis patients and its alteration under the influence of interferon preparations].
    Medunitsyn NV; Avdeeva ZhI; Mazina NM; Krylov OR; Lukasheva TV
    Vestn Dermatol Venerol; 1989; (4):10-4. PubMed ID: 2503955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoenzyme analysis of the change in the expression of class II antigens of the major histocompatibility complex under the influence of interferon preparations].
    Kremlev SG; Medunitsyn NV
    Biull Eksp Biol Med; 1989 Nov; 108(11):577-80. PubMed ID: 2517405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
    Kelley VE; Fiers W; Strom TB
    J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
    Guo TL; Mudzinski SP; Lawrence DA
    Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver.
    Sato Y; Tsukada K; Matsumoto Y; Abo T
    Hepatology; 1993 Aug; 18(2):340-6. PubMed ID: 8340062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthropathy.
    Lan CC; Tsai WC; Wu CS; Yu CL; Yu HS
    Br J Dermatol; 2004 Jul; 151(1):24-31. PubMed ID: 15270869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.
    Rhodes J; Jones DH; Bleehen NM
    Clin Exp Immunol; 1983 Sep; 53(3):739-43. PubMed ID: 6311468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes.
    Gerber LH; Murray CL; Perlman SG; Barth WF; Decker JL; Nigra TA; Mann DL
    J Rheumatol; 1982; 9(5):703-7. PubMed ID: 6816931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan.
    Becker S
    J Immunol; 1984 Mar; 132(3):1249-54. PubMed ID: 6420462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
    Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE
    Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris].
    Volk HD; Diezel W; Waschke SR; Barthelmes H; Grunow R; Fiebig H; Sönnichsen N
    Dermatol Monatsschr; 1985; 171(5):308-11. PubMed ID: 3926547
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
    Gonwa TA; Frost JP; Karr RW
    J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.